plasma zinc level in hepatitis c patients with or without beta thalassemia major; is there any difference?

نویسندگان

mohammad abbasinazari department of clinical pharmacy, shahid beheshti university of medical sciences, tehran, ir iran; department of clinical pharmacy, shahid beheshti university of medical sciences, tehran, ir iran. tel: +98-9123431245, fax: +98-2188873704

bita behnava baqiyatallah research center for gastroenterology and liver disease, baqiyatallah university of medical sciences, tehran, ir iran

yunes panahi chemical injuries research center, baqiyatallah university of medical sciences, tehran, ir iran

azita hajhossein talasaz department of clinical pharmacy, school of pharmacy, tehran university of medical sciences, tehran, ir iran

چکیده

results mean ± standard deviation (sd) of plasma zinc levels was determined as 0.78 ± 0.22 mg/l. also zinc level was 0.76 ± 0.19 mg/l and 0.80 ± 0.24 mg/l in thalassemic and non thalassemic patients, respectively. t-test analysis showed that there is no significant difference between these two groups regarding plasma zinc level (p = 0.235). conclusions it is concluded that zinc level of studied patients is less than which is reported in normal iranian population. moreover, there is not a significant difference in plasma zinc levels between thalassemic and non thalassemic patients and it seems to be a common problem in both ones. addition of zinc supplement may be recommended in both groups in order to optimize the nutritional support and probably improve the treatment response. background zinc deficiency has been reported frequently in hepatitis c patients in the literature. furthermore, a decrease in zinc level has been shown in beta thalassemia major as well. iranians consume a large amount of phytate in their regimens which can bind with zinc and decrease its gastrointestinal absorption. objectives this study was designed to determine plasma zinc level in an iranian sample with the diagnosis of hepatitis c with or without concomitant beta thalassemia major. patients and methods between april 2011 and april 2012, plasma zinc level was determined via atomic absorption method, in 130 hepatitis c patients with or without beta thalassemia major in a known referral center of hepatic diseases in tehran, iran.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Plasma Zinc Level in Hepatitis C Patients With or Without Beta Thalassemia Major; Is There Any Difference?

BACKGROUND Zinc deficiency has been reported frequently in hepatitis C patients in the literature. Furthermore, a decrease in zinc level has been shown in beta thalassemia major as well. Iranians consume a large amount of phytate in their regimens which can bind with zinc and decrease its gastrointestinal absorption. OBJECTIVES This study was designed to determine plasma zinc level in an Iran...

متن کامل

Serum Adiponectin Level in Diabetic Patients with and without Helicobacter pylori Infection: Is There Any Difference?

BACKGROUND Increased insulin resistance is an extragastrointestinal manifestation of Helicobacter pylori (HP) infection. HP changes the level of inflammatory markers and cytokines and changes the adipocyte function by altering the adiponectin level. Given the high prevalence of HP and diabetes in our society, we evaluated the association between HP and serum adiponectin level. In this cross-sec...

متن کامل

Sofosbuvir based therapy in hepatitis C patients with and without cirrhosis: Is there difference?

OBJECTIVE To compare sustained viral response to sofosbuvir/ribavirin ±interferon therapy in patients of hepatitis C with and without liver cirrhosis. METHODS This observational study of chronic hepatitis C patients was carried out at Doctors Hospital and Medical Center (DH&MC). After diagnostic workup, Sofosbuvir/ribavirin for 24 weeks or sofosbuvir/ribavirin/pegylated interferon for 12 week...

متن کامل

Cytokine Gene Polymorphisms in Iranian Patients with Beta-Thalassemia Major

Background: β-thalassemia as a hereditary disease is defined as defective synthesis of   β-globin chains, resulting in erythropoiesis abnormalities and severe anemia. Different studies have shown that cytokines and cytokine gene polymorphisms play a major role in the pathogenesis of   β-thalassemia. Single nucleotide polymorphisms (SNPs) within the promoter region or other regulatory sequences ...

متن کامل

A Cross-Sectional Study of Glycemic Status and Zinc Level in Patients with Beta-Thalassemia Major

Background: Endocrinopathies and diabetes mellitus are prevalent in patients with beta-thalassemia major Recently some studies demonstrate a link between low levels of serum zinc level and higher prevalence of diabetes. The aim of this study was to evaluate the glucose tolerance in patients suffered from beta-thalassemia major and determine the association of Homeostasis Model Assessment (HOMA)...

متن کامل

Endocrine Disorders in Beta thalassemia Major Patients

Background Thalassemia is the most common hereditary disorder worldwide. The patient's’ survival is dependent on lifetime blood transfusion which leads to iron overload and its toxicity on various organs including endocrine glands. The study aimed to investigate endocrine disorders in patients with Beta-thalassemia major in the Southern Khorasan province, Iran. Materials and Methods In this des...

متن کامل

منابع من

با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید


عنوان ژورنال:
hepatitis monthly

جلد ۱۳، شماره ۸، صفحات ۰-۰

کلمات کلیدی

میزبانی شده توسط پلتفرم ابری doprax.com

copyright © 2015-2023